TPPP Polyclonal Antibody

Promotes in vitro the polymerization of tubulin into double-walled tubules and polymorphic aggregates or bundled stabilized microtubules blocks. When overexpressed, inhibits mitotic spindle assembly and nuclear envelope breakdown, apparently without affecting other cellular events.,PTM:Phosphorylated by TPK II. Poor substrate for GSK3.,Belongs to the TPPP family.,subunit:May form dimers. Binds tubulin; binding is inhibited by GTP. Interacts with GSK3.,tissue specificity:Widely expressed.,

Introducing the TPPP Polyclonal Antibody, a cutting-edge immunological tool designed to revolutionize research and diagnostics in the field of neuroscience. This meticulously crafted antibody is derived from a polyclonal source, ensuring a diverse range of binding sites for enhanced specificity and sensitivity.

The TPPP Polyclonal Antibody exhibits exceptional affinity towards the target protein, TPPP/p25, a key regulator of microtubule dynamics implicated in neurodegenerative disorders. Through its robust binding capabilities, this antibody enables precise detection and quantification of TPPP/p25 expression levels, facilitating comprehensive investigations into its functional role and potential therapeutic interventions.

Crafted with utmost precision and quality, the TPPP Polyclonal Antibody guarantees reproducibility and reliability in experimental settings. Its exceptional specificity minimizes cross-reactivity, ensuring accurate and precise results. Furthermore, this antibody demonstrates exceptional stability, allowing for long-term storage without compromising its performance.

The TPPP Polyclonal Antibody is compatible with a wide range of applications, including immunohistochemistry, western blotting, and immunofluorescence. Its versatility enables researchers and clinicians to explore TPPP/p25 expression patterns in various biological samples, including tissue sections, cell cultures, and animal models.

In summary, the TPPP Polyclonal Antibody represents a breakthrough in neuroscience research, offering unparalleled sensitivity, specificity, and versatility. With its exceptional performance and reliability, this antibody is poised to accelerate advancements in understanding TPPP/p25 biology and pave the way for novel therapeutic strategies in neurodegenerative disorders.